With our MOG model, Holden harnesses multidisciplinary expertise to advance cancer treatment. 

Researchers and clinicians at Holden Comprehensive Cancer Center collaborate through multidisciplinary oncology groups (MOGs), which unite experts across specialties to integrate research and clinical care. Holden also leads specialized programs of research excellence (SPOREs), advancing focused areas of translational cancer research.

Each cancer type has a dedicated MOG that brings together basic scientists, translational investigators, and clinical specialists to accelerate the development and application of new therapeutic strategies. These teams evaluate emerging data, design and implement clinical trials, and use collective expertise to inform personalized treatment plans tailored to each patient—ensuring that every patient benefits from the most current evidence and promising treatment options available.